Covid-19 struck US man twice, and second time was worse

The degree of protective immunity after a Covid-19 infection is one of the pandemic's great unknowns

coronavirus
Photo: Bloomberg
Suzi Ring | Bloomberg
3 min read Last Updated : Oct 13 2020 | 3:15 PM IST
The first study to investigate the case of a person in the U.S. who contracted Covid-19 twice found reinfection can occur swiftly and the second bout of illness can be more severe.

The research, published in the Lancet medical journal, examined the case of a 25-year-old man living in Nevada who became infected with two different genetic variants of the SARS-CoV-2 virus in less than two months. He tested negative twice in between, meaning he’s unlikely to have suffered a single prolonged infection.

The findings come as U.S. President Donald Trump says he’s immune to the virus after a single encounter. Any new findings on resistance can also have implications for a vaccine as drugmakers race toward the finish line.

The degree of protective immunity after a Covid-19 infection is one of the pandemic’s great unknowns.

So far a handful of reinfection cases have been recorded since the start of the outbreak late last year. One patient in Ecuador also suffered a worse bout of illness the second time around and an elderly woman in the Netherlands died after testing positive a second time. It’s also possible people with no symptoms could be infected multiple times without knowing it.

The Nevada man first tested positive for the virus mid-April after experiencing a headache, coughing, nausea and diarrhea. He had no underlying conditions that could’ve worsened his illness. He isolated and got better by the end of the month.

Oxygen Needed
 
At the end of May, though, the man consulted at an urgent care center with fever and dizziness in addition to the symptoms he’d experienced the prior month. Five days later he was hospitalized with shortness of breath and given oxygen before testing positive for Covid-19 once more.

Scientists sequenced the genomes of the patient’s virus samples and found significant differences, suggesting the man was infected by two distinct versions of the coronavirus.

The researchers said they couldn’t be sure why the second infection was worse. It’s possible the patient was exposed to a higher dose of virus the second time, that the version he encountered was more virulent or even that the presence of antibodies from the first infection was to blame in a twist observed with another coronavirus. It’s even possible -- but unlikely -- that there was a continuous infection with some sort of deactivation-reactivation dynamic, they wrote.

“There are still many unknowns,” said Mark Pandori, director of the Nevada State Public Health Laboratory and lead author of the study. “Our findings signal that a previous SARS-CoV-2 infection may not necessarily protect against future infection. The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine.”

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsUS

Next Story